Previous Article | Next Article ![]()
Journal of Clinical Microbiology, April 1998, p. 913-917, Vol. 36, No. 4
Department of Medical Microbiology,
Received 29 September 1997/Returned for modification 11 November
1997/Accepted 23 December 1997
Enzyme immunoassay (EIA) is an ideal method for screening large
numbers of patients for syphilis. We evaluated a novel immune-capture EIA (ICE Syphilis; Murex Diagnostics) that uses three recombinant Treponema pallidum antigens (TpN15, TpN17, and TpN47) and
compared the results with those obtained by the native T. pallidum antigen EIA (Captia SelectSyph-G; Centocor) that we
currently use for the serodiagnosis of syphilis. Specificity was
evaluated by screening 1,184 unselected serum specimens in parallel by
the ICE Syphilis and SelectSyph-G assays, while sensitivity was tested
with a panel of 101 serum specimens containing antitreponemal
antibodies (treated and untreated) from patients with various stages of
infection. The specificity of the ICE Syphilis EIA (99.8%) on
screening was significantly higher (P < 0.02) than
that of the SelectSyph-G EIA (99.2%). The sensitivity of the ICE
Syphilis EIA was significantly higher (P < 0.01) than
that of the SelectSyph-G EIA on both initial (99 versus 91.4%) and
repeat (100 versus 92.4%) testing. The ICE Syphilis EIA was also
significantly more sensitive (P < 0.01) than the
fluorescent treponemal antibody-abs (92.4%) but not the T. pallidum hemagglutination assay (97.1%). Sera containing
antitreponemal antibodies gave a much higher antibody index (absorbance
of test serum/kit cutoff) by the ICE Syphilis EIA than by the
SelectSyph-G EIA. This combined with the overall high sensitivity makes
the ICE Syphilis EIA an ideal test for excluding or detecting
treponemal infection in human immunodeficiency virus (HIV)-infected
patients. The ICE Syphilis EIA was positive with sera from all 15 HIV-infected patients in the study, whereas sera from 3 HIV-infected
patients were negative by the SelectSyph-G EIA. We conclude that the
high sensitivity and specificity of the ICE Syphilis EIA and its
suitability for automation make it an ideal screening test.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Novel Recombinant-Antigen Enzyme Immunoassay for
Serological Diagnosis of Syphilis
*
Corresponding author. Mailing address: Department of
Medical Microbiology, Edinburgh University Medical School, Teviot
Place, Edinburgh EH8 9AG, Scotland, United Kingdom. Phone: 0131 650 3143. Fax: 0131 650 3144. E-mail:
hugh.young{at}ed.ac.uk.
Journal of Clinical Microbiology, April 1998, p. 913-917, Vol. 36, No. 4
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»